Lexicon Pharmaceuticals | LXRX - PE Price to Earnings

Stock Price
1.31
Daily Change
0 0%
Monthly
5.65%
Yearly
66.90%
Q1 Forecast
2.01

Lexicon Pharmaceuticals reported 12.44 in PE Price to Earnings for its fiscal quarter ending in June of 2021.





Pe Change Date
Abbott USD 30.71 14.41 Dec/2025
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Agios Pharmaceuticals USD 3.56 0.68 Sep/2025
Akebia Therapeutics 26.5 0.19 Sep/2023
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
AstraZeneca USD 27.29 5.8 Dec/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
Halozyme Therapeutics USD 15.46 3.56 Sep/2025
Illumina USD 30.38 15.53 Dec/2025
Ironwood Pharmaceuticals USD 204.24 88.19 Dec/2024
J&J USD 23.62 0.86 Dec/2025
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
MannKind USD 30.56 6.84 Sep/2025
Merck USD 13.92 5.08 Dec/2025
Moderna USD 27.22 14.51 Jun/2023
Novartis USD 15.74 0.15 Sep/2025
PTC Therapeutics USD 6.73 0.26 Sep/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Sarepta Therapeutics USD 27.27 0 Jun/2025
Thermo Fisher Scientific USD 31 6.22 Dec/2025
United Therapeutics USD 15.7 4.24 Sep/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023